|
|||||
|
|
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes |
|
| Authors: | Quincy S. C. Chu Bahram Forouzesh Samira Syed Monica Mita Garry Schwartz Joshua Cooper Janet Curtright Eric K. Rowinsky |
| Affiliation: | (1) Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada;(2) Institute for Drug Development, Cancer Therapy and Research Center, University of Texas Health Sciences Center, San Antonio, TX, USA;(3) Brooke Army Medical Center, Fort Sam Houston, TX, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |